Anderson, San Diego
Carole Lee Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20080206467 | Method of prevention of coating defects - In accordance with the present invention, a method of prevention of defects in uniform coatings is proposed. The method comprises decelerating the advancement of the dewetting front of a coating attained by externally controlling the wettability and the size of a buffer zone at the boundary of the coating area. The surface of the buffer zone should have better wettability with respect to the fluid in the coating than the surface of the coating area. | 08-28-2008 |
Chad Jerell Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090037206 | Method of forecasting maintenance of a machine - A method of forecasting maintenance of a machine is disclosed. The method includes measuring a parameter of the machine, the parameter being indicative of a condition of the machine, and transferring the measured parameter to a maintenance planning system. The method also includes predicting two or more parameter variation curves indicating the variation of the parameter over time, each parameter variation curve representing values of the parameter at a different confidence level. The method further includes identifying a first time period for maintenance of the machine based on the two or more parameter variation curves. | 02-05-2009 |
Christen Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100323955 | METHODS FOR TREATING OBESITY AND OBESITY RELATED DISEASES AND DISORDERS - Methods for treating obesity or obesity related disorders are disclosed. These methods include the use of anti-obesity agents directed to the forebrain in combination with anti-obesity agents directed to the hindbrain. | 12-23-2010 |
Corey Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090176769 | CGRP RECEPTOR ANTAGONISTS - The present invention relates to CGRP receptor antagonists, pharmaceutical compositions thereof, and methods therewith for treating CGRP receptor-mediated diseases and conditions. | 07-09-2009 |
20110077269 | DERIVATIVES FOR MODULATION OF ION CHANNELS - Sulfonamide derivatives act as ion channel antagonists. The compositions are useful for treating or relieving pain-related conditions. | 03-31-2011 |
20110082117 | PHENYL SULFONAMIDES AS MODULATORS OF ION CHANNELS - The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. | 04-07-2011 |
20110098328 | HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS - The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. | 04-28-2011 |
20110178061 | HETEROCYCLIC DERIVATIVES FOR MODULATION OF CALCIUM CHANNELS - Heterocyclic derivatives act as Ca channel antagonists. The compositions are useful for treating or relieving Ca channel mediated conditions. | 07-21-2011 |
20110306607 | HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS - The invention relates to heterocyclic chromene-spirocyclic piperidine amides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. | 12-15-2011 |
20120149742 | HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS - The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. | 06-14-2012 |
20120178713 | PHENYL SULPHONAMIDES AS MODULATORS OF ION CHANNELS - The present invention relates to phenyl sulfonamides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, including for example the treatment of pain. | 07-12-2012 |
20120196869 | PYRROLOPYRAZINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS - The invention relates to pyrrolopyrazine-spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. | 08-02-2012 |
20130035310 | Piperidine and Piperazine Phenyl Sulfonamides as Modulators of Ion Channels - The present invention relates to piperidine and piperazine phenyl sulfonamides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, including for example the treatment of pain. | 02-07-2013 |
20140171427 | Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels - The invention relates to heterocyclic chromene-spirocyclic piperidine amides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. | 06-19-2014 |
20140213616 | PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS - The invention relates to pyridone amide compounds of formula I and I′ or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels: | 07-31-2014 |
20140221435 | AMIDES AS MODULATORS OF SODIUM CHANNELS - The invention relates to amide compounds of formula I and I′ or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels: | 08-07-2014 |
20140309220 | BENZOXAZINES AS MODULATORS OF ION CHANNELS - The invention relates to benzoxazines useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. | 10-16-2014 |
20150174127 | Pyrrolopyrazine-Spirocyclic piperidine amides as modulators of ion channels - The invention relates to pyrrolopyrazine-spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. | 06-25-2015 |
20150246028 | PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS - The invention relates to pyridone amide compounds of formula I and I′ or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels: | 09-03-2015 |
20150328196 | AMIDES AS MODULATORS OF SODIUM CHANNELS - The invention relates to amide compounds of formula I and I′ or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels: | 11-19-2015 |
20150336945 | QUINOLINE AND QUINAZOLINE AMIDES AS MODULATORS OF SODIUM CHANNELS - The invention relates to compounds of formula I or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels: | 11-26-2015 |
20160095858 | Modulators of Cystic Fibrosis Transmembrane Conductance Regulator - The present invention features a compound of formula I: | 04-07-2016 |
Corey Don Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090186882 | CGRP RECEPTOR ANTAGONISTS - The present invention relates to CGRP receptor antagonists, pharmaceutical compositions thereof, and methods therewith for treating CGRP receptor-mediated diseases and conditions. | 07-23-2009 |
20100004300 | HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS - The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. | 01-07-2010 |
Dean A. Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090292986 | POPULATING DYNAMIC PAGE TEMPLATE WITH DIGITAL CONTENT OBJECTS - A dynamic page template is populated with one or more digital content objects, comprising. For each digital content object, a locus is determined in relation to the dynamic page template. The locus specifies locations on the dynamic page template at which the digital content object can be placed. The digital content object is then placed on the dynamic page template at one of the locations specified by the locus. The digital content objects placed on the dynamic page template are algorithmically manipulated one or more times to change sizes and/or locations of one or more of the digital content objects. The dynamic page template is then output. | 11-26-2009 |
Janice S. Anderson, San Diego, CA US
Jeffery Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090270373 | TREATMENT OF DOWN SYNDROM WITH BENZODIAZEPINE RECEPTOR ANTAGONISTS - Pharmaceutical compositions and methods of treating Down Syndrome, mental retardation or both are provided. The pharmaceutical compositions comprise one or more benzodiazepine receptor antagonists, such as flumazenil. | 10-29-2009 |
Jeffery J. Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090048233 | Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination - Provided are combinations of pharmaceutical agents capable of eliciting a therapeutic effect. A first therapeutic agent in the combination has 5HT | 02-19-2009 |
20090275562 | TOLERABILITY OF MIRTAZAPINE AND A SECOND ACTIVE BY USING THEM IN COMBINATION - A reduction in the side effects of treating with an agent having combined 5HT | 11-05-2009 |
20100160294 | TOLERABILITY OF MIRTAZAPINE AND A SECOND ACTIVE BY USING THEM IN COMBINATION - A reduction in the side effects of treating with an agent having combined 5HT | 06-24-2010 |
20100204205 | TOLERABILITY OF MIRTAZAPINE AND A SECOND ACTIVE AGENT BY USING THEM IN COMBINATION - A reduction in the side effects of treating with an agent having combined 5HT2/5HT3 and alpha-2 antagonistic activity is obtained by administering an agent having histamine H1 receptor agonist activity. A combined dosage form comprising an agent having 5HT2/5HT3 and alpha-2 antagonistic activity and an agent having histamine H1 receptor agonist activity is presented. Some embodiments of the combined dosage form comprise an immediate release component comprising an agent having 5HT2/5HT3 and alpha-2 antagonistic activity and a delayed release component comprising an agent having histamine H1 receptor agonist activity. Some embodiments of the combined dosage form comprise a delayed release component comprising an agent having 5HT2/5HT3 and alpha-2 antagonistic activity and an immediate release component comprising an agent having histamine H1 receptor agonist activity. Methods of treatment and kits for administration are also provided. | 08-12-2010 |
Jeffrey G. Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100049721 | Local Agent for Remote File Access System - Systems and methods for remote file access are disclosed: According to an embodiment, a local agent polls a server for a task request at a polling interval scheduled by a schedule timer in accordance with a set of local agent and remote client preferences. The local agent is responsible for executing a task from the task request and causing a file to be uploaded to the server. The local agent uses a task processor for polling a server, a schedule timer for controlling polling, and one or more protocol stacks, such as TCP/IP and SOAP, for communicating with the server. The local agent can also interface with a MAPI database for message delivery. | 02-25-2010 |
John Christopher Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20080227152 | In vivo incorporation of unnatural amino acids - The invention provides methods and compositions for in vivo incorporation of unnatural amino acids. Also provided are compositions including proteins with unnatural amino acids. | 09-18-2008 |
20080261311 | In vivo incorporation of unnatural amino acids - The invention provides methods and compositions for in vivo incorporation of unnatural amino acids. Also provided are compositions including proteins with unnatural amino acids. | 10-23-2008 |
20090053791 | Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs - This invention provides compositions and methods for generating components of protein biosynthetic machinery including orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases, and orthogonal pairs of tRNAs/synthetases. Methods for identifying orthogonal pairs are also provided. These components can be used to incorporate unnatural amino acids into proteins in vivo. | 02-26-2009 |
20090068717 | In vivo incorporation of unnatural amino acids - The invention provides methods and compositions for in vivo incorporation of unnatural amino acids. Also provided are compositions including proteins with unnatural amino acids. | 03-12-2009 |
20110027867 | Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs - This invention provides compositions and methods for generating components of protein biosynthetic machinery including orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases, and orthogonal pairs of tRNAs/synthetases. Methods for identifying orthogonal pairs are also provided. These components can be used to incorporate unnatural amino acids into proteins in viva | 02-03-2011 |
Jon J. Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110296064 | UPLINK DATA THROTTLING BY BUFFER STATUS REPORT (BSR) SCALING - A technique for uplink data throttling includes buffer status report (BSR) scaling. A target data flow rate may be determined based on at least on condition of a wireless device. The buffer status report may be adjusted to cause the target flow rate and transmitted by the wireless device. The wireless device may then receive a flow control command based on the buffer status report. | 12-01-2011 |
20120176898 | DOWNLINK FLOW CONTROL USING PACKET DROPPING TO CONTROL TRANSMISSION CONTROL PROTOCOL (TCP) LAYER THROUGHPUT - Certain aspects of the present disclosure relate to wireless communications and methods and apparatus for downlink flow control at a user equipment (UE). Aspects generally include monitoring, by a UE, one or more parameters related to the UE, and selectively dropping received packets based on the one or more parameters in order to trigger a rate control mechanism. Selectively dropping received packets may occur at a Packet Data Convergence Protocol (PDCP) layer in order to reduce a corresponding transmission control protocol (TCP) throughput. Accordingly, packets may be selectively dropped prior to reaching an applications processor. | 07-12-2012 |
Keith Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100280119 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF - Disclosed herein are crystalline forms of L-ornithine phenyl acetate and methods of making the same. The crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate. | 11-04-2010 |
20120157526 | TREATMENT OF PORTAL HYPERTENSION AND RESTORATION OF LIVER FUNCTION USING L-ORNITHINE PHENYLACETATE - Disclosed herein are methods of treating and/or preventing portal hypertension and/or restoring liver function using L-ornithine phenylacetate. | 06-21-2012 |
20120208885 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF - Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate. | 08-16-2012 |
20130296429 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF - Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate. | 11-07-2013 |
20140288327 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF - Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate. | 09-25-2014 |
20150251990 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF - Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate. | 09-10-2015 |
Keith H. Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20130211135 | METHODS OF MAKING L-ORNITHINE PHENYL ACETATE - Disclosed herein are processes for making L-ornithine phenyl acetate. The process may include, for example, inter-mixing a halide salt of L-ornithine with silver phenyl acetate. The process may also include forming a phenyl acetate salt in situ. The present application also relates to various compositions obtained from these processes, including crystalline forms. | 08-15-2013 |
20150133684 | METHODS OF MAKING L-ORNITHINE PHENYL ACETATE - Disclosed herein are processes for making L-ornithine phenyl acetate. The process may include, for example, intermixing a halide salt of L-ornithine with silver phenyl acetate. The process may also include forming a phenyl acetate salt in situ. The present application also relates to various compositions obtained from these processes, including crystalline forms. | 05-14-2015 |
Kraig Lamar Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100202501 | ADAPTIVE ACKNOWLEDGING AND POWER CONTROL - A communication device wirelessly coupled to another communication device. The communication device includes a first transmitter and a first receiver. The first transmitter is configured to transmit first power control bit information to the base station over a reverse link. The first transmitter has a timeline manager, configured to transmit the first power control bit information at a first rate according to a first pattern within a frame. The first receiver is configured to receive second power control bit information from the another communication device over a forward link. The first receiver has an adaptive controller, configured to determine the first rate and the first pattern. The first rate and the first pattern are selected from a plurality of rates and patterns available for transmission of the first power control bit information and the second power control bit information. | 08-12-2010 |
Matthew K. Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20130231760 | REAL-TIME EVENT FEEDBACK - Methods, systems and devices are provided for presenting event feedback information regarding participants to an event. A first radio of a first participant device carried by a first participant receives a first checkpoint communication from a checkpoint device at a first checkpoint located along a first course of the event. The first checkpoint communication includes a first checkpoint identifier and a first event time reflecting when the first participant crossed the first checkpoint. A first checkpoint event time is determined based upon the first checkpoint identifier and the first event time. Also, the first checkpoint event time is displayed on the first participant device. Further, a checkpoint device and an event server may be used to in presenting the event feedback information. | 09-05-2013 |
Michael D. Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20080219795 | FLEXIBLE TRUCK BED TIE-DOWN SYSTEM - A flexible cargo bed tie-down system allows the user to easily change, adjust, customize, and adapt his or her vehicle to specific needs at any given moment, and interfaces with the rest of the vehicle in an optimum manner from a functional, structural, and aesthetic standpoint. One embodiment of the invention provides a vehicle having a side wall construction enclosing a cargo bed at a side of the cargo bed. The side wall construction includes an outer portion which runs generally vertically at an outer portion of the vehicle, and a top portion which runs generally horizontally from the outer portion toward a longitudinal center of the vehicle. A tie-down rail is mounted adjacent to the top portion such that a part of the top portion overhangs at least a portion of the tie-down rail. The tie-down rail is configured to accept a tie-down fitting and includes a slotted opening generally aligned with an interior edge of the top portion. | 09-11-2008 |
Paul Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100153531 | DECOUPLED LOGICAL AND PHYSICAL DATA STORAGE WITHIN A DATBASE MANAGEMENT SYSTEM - The subject matter herein relates to database management systems and, more particularly, to decoupled logical and physical data storage within a database management system. Various embodiments provide systems, methods, and software that separate physical storage of data from logical storage of data. These embodiments include a mapping of logical storage to physical storage to allow data to be moved within the physical storage to increase database responsiveness. | 06-17-2010 |
20140115756 | Linked Belt - A device enabling the formation of a belt or suspenders through a sequential engagement of a plurality of removably engageable bodies. The bodies are only engageable and disengageable when positioned at an engagement position substantially perpendicular to adjacent bodies. | 05-01-2014 |
Russell J. Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090036838 | Methods of Administering Microparticles Combined With Autologous Body Components - Microspheres to be implanted into a patient are metered and mixed with fluids, cells, or tissues withdrawn from the patient's own body, and reinserted into the patient's body to achieve augmentation, repair or other treatment of the patient's tissue. | 02-05-2009 |
20100172829 | ENHANCED CARRIERS FOR THE DELIVERY OF MICROPARTICLES TO BODILY TISSUES AND FLUIDS - Improved compositions for tissue augmentation are provided. These compositions comprise an amount of crosslinked material sufficient to provide a melt temperature (T | 07-08-2010 |
20130041326 | INJECTION APPARATUS FOR LONG DISTANCE DELIVERY OF SOFT TISSUE BULKING AGENTS CONTAINING MICROSPHERES - An injection device is formed as a long tubular structure with a wire that controls a piston in the structure from a proximal end, allowing therapeutic material to be injected into a patient through a needle at a distal end. | 02-14-2013 |
20140056982 | Enhanced Carriers For The Delivery of Microparticles To Bodily Tissues And Fluids - Improved compositions for tissue augmentation are provided. These compositions comprise an amount of crosslinked material sufficient to provide a melt temperature (T | 02-27-2014 |
Ryan Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20150322389 | FILTER ASSEMBLY FOR USE WITH A WIDE-MOUTH FERMENTATION CARBOY - The disclosure concerns a filter assembly adapted for use with a wide mouth carboy in the field of home brewing, and home brewing kits comprising the same. The filter assembly generally includes a carboy lid adapted to engage a fermentation carboy, a mesh filter tube extending from a bottom side of the carboy lid, wherein through an aperture of the lid and into the volume within the mesh filter tube is defined a mesh cavity. Materials can be introduced into the mesh cavity for brewing applications. An agitation probe forms part of the home brewing kit and is used for: (i) agitating the materials within the mesh cavity during a brewing process; (ii) pressing the materials to extract fluids therefrom; or (iii) a combination thereof. | 11-12-2015 |
Spencer C. Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20130314465 | PRINTING SYSTEM AND RELATED METHODS - In one embodiment, a printing system includes a printhead module that has a printhead and a regulator chamber. The regulator chamber contains ink and a regulator air bag. The regulator air bag and the printhead are in fluid communication with the ink, and the printhead includes a plurality of ejection nozzles. The printing system includes a pressure source to inflate the air bag, thereby displacing an amount of ink sufficient to agitate menisci in the ejection nozzles without pushing ink out of the nozzles. | 11-28-2013 |
Steven Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20140050082 | DEVICES, SYSTEMS, AND METHODS FOR ADAPTIVE SWITCHING OF MULTICAST CONTENT DELIVERY TO OPTIMIZE BANDWIDTH USAGE - Systems, devices and methods for adaptive switching in multicast media streams are disclosed herein. In an embodiment, a method for adaptively transmitting content to one or more users based on currently available bandwidth via internet protocol (“IP”) multicast protocol, includes: receiving a first content stream having a plurality of data packets, the first content stream encoded at a first bit rate; receiving a second content stream having a plurality of data packets, the second content stream encoded at a second bit rate, wherein the first bit rate is different than the second bit rate and wherein the first and second content streams represent the same content; transmitting the first content stream to a user; determining that the user could receive the second content stream based on available bandwidth for transmitting data to the user; and transmitting the second content stream to the user. | 02-20-2014 |
20150181266 | INHERITANCE BASE RIGHT OBJECT FILE GENERATION AND MANAGEMENT SCHEME IN A HOME SERVER - A Digital Rights Management (DRM) system is provided to manage license rights for video object files where both parent and child object files are created. In the system a license library is provided, the license library including data identifying a parent object file allowing access to first video content and child object files relating to the parent object file also allowing access to the first video content. Further, the system creates a data tree structure with a parent pointer identifying the child object files related to the parent, and child pointers identifying the parent pointer related to the child. The data tree structure is used to modify the license library when a first request is received to modify one of the parent object files or the child object files. When a copy count is used and decremented when additional copies are made, the system updates the pointers in the data tree structure accordingly. | 06-25-2015 |
Steven E. Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090138609 | Method and Apparatus for Maintaining User Sessions Across User Devices and Portals - Embodiments of the invention generally provide a method and apparatus for maintaining user sessions across user devices and portals. One embodiment of a method for maintaining a user session across a group including a plurality of user devices includes altering, at a first device in the group, a state of the user session, such that a new session state results and transferring the new session state from the first device to at least one of the other devices in the group. | 05-28-2009 |
Tyler Anderson, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20160052094 | SYSTEM AND METHOD FOR METALIZING VERTICALLY ALIGNED CARBON NANOTUBE ARRAY - A method for metallizing a vertically aligned carbon nanotube array includes coupling a support structure to an actuator, the support structure supporting a vertically aligned carbon nanotube array, and vibrating the support structure with the actuator. The method can also include the step of fixedly positioning the actuator between a first member and a second member. The vibration can be consistent or it can vary in amplitude and/or frequency over time. The step of fixedly positioning can include the first member having a first mass and the second member having a second mass that is different or less than the first mass. The actuator can include a piezoelectric element. A metalizing assembly for intercalating a vertically aligned carbon nanotube array with a metal includes a first member, a support structure, a second member and an actuator. The support structure is coupled to the first member. The support structure supports the vertically aligned carbon nanotube array. The second member is coupled to the support structure. The actuator is positioned between the first member and the second member. The actuator vibrates the support structure. | 02-25-2016 |